Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Equity Ratio (2016 - 2025)

Standard Biotools (LAB) has disclosed Equity Ratio for 16 consecutive years, with 0.75 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 2.99% to 0.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75 through Dec 2025, down 2.99% year-over-year, with the annual reading at 0.75 for FY2025, 2.99% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.75 at Standard Biotools, up from 0.74 in the prior quarter.
  • The five-year high for Equity Ratio was 0.78 in Q1 2025, with the low at 0.46 in Q4 2023.
  • Average Equity Ratio over 5 years is 0.28, with a median of 0.37 recorded in 2021.
  • The sharpest move saw Equity Ratio plummeted 421.47% in 2023, then surged 383.99% in 2024.
  • Over 5 years, Equity Ratio stood at 0.34 in 2021, then plummeted by 160.73% to 0.21 in 2022, then crashed by 119.56% to 0.46 in 2023, then surged by 268.1% to 0.77 in 2024, then fell by 2.99% to 0.75 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.75, 0.74, and 0.76 for Q4 2025, Q3 2025, and Q2 2025 respectively.